Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Stress Reduction During In Vitro Fertilization

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified May 2010 by Stanford University.
Recruitment status was:  Recruiting
Information provided by:
Stanford University Identifier:
First received: November 6, 2008
Last updated: May 21, 2010
Last verified: May 2010
The goal of this study is to determine the effect of Healing Touch (HT) on the stress, anxiety, and self-efficacy experiences of women undergoing in vitro fertilization (IVF) in a randomized, controlled design. HT is a gentle, non-invasive form of energy-balancing work that promotes relaxation.

Condition Intervention
Behavioral: Healing Touch
Behavioral: Desensitization Therapy
Behavioral: Standard Care

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: Stress Reduction During In Vitro Fertilization

Resource links provided by NLM:

Further study details as provided by Stanford University:

Primary Outcome Measures:
  • Spielberger State Trait Anxiety Inventory [ Time Frame: 30 days ]

Secondary Outcome Measures:
  • Perceived Stress Scale [ Time Frame: 30 days ]
  • Infertility Self-Efficacy Scale [ Time Frame: 30 days ]
  • Pregnancy outcome [ Time Frame: 30 days ]

Estimated Enrollment: 45
Study Start Date: October 2008
Estimated Study Completion Date: December 2011
Estimated Primary Completion Date: December 2010 (Final data collection date for primary outcome measure)
Detailed Description:

Once enrolled, each participant will be randomized to one of three groups: the Healing Touch (HT) treatment arm, the Desensitization Therapy (DT) arm, or the no-intervention arm.

Subjects in Group 1 will receive three, 45-minute HT sessions during the first two weeks of their IVF cycle prior to oocyte retrieval. Group 2 will receive three, 45-minute DT sessions during the first two weeks of their IVF cycle prior to oocyte retrieval. Group 3 will receive no intervention. Subjects in Group 3 will be offered two HT sessions after completing study participation.

All subjects and their partners will be asked to complete the Spielberger State Trait Anxiety Inventory (STAI), the Perceived Stress Scale (PSS) and the Infertility Self-Efficacy Scale (ISES) at three time points: 1) baseline 2) one day prior to oocyte retrieval and 3) 5-7 days post embryo transfer. In addition, subjects in all groups will complete a short pre-study questionnaire to assess expectation of therapeutic effect, and subjects in the two intervention groups will complete a short post-study questionnaire to evaluate their treatment experience. Demographic and pregnancy outcome data will be collected for all subjects.


Ages Eligible for Study:   18 Years to 42 Years   (Adult)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   No

Inclusion Criteria:-Age <43

  • FSH <= 14
  • About to enter an IVF cycle at the Stanford Fertility and Reproductive Medicine Center
  • Planning a transfer of their own fresh embryos during this cycle
  • Speak and read English fluently

Exclusion Criteria:-Diminished ovarian reserve

  • Planning to freeze their embryos without embryo transfer during this cycle
  • Planning to use donor eggs or embryos during this cycle
  • Concomitant energy work interventions (HT, Reiki, QiGong, acupuncture) planned during the IVF cycle.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00788502

Contact: Kathy Turner, RN, NP (650) 724-6850

United States, California
Stanford University School of Medicine Recruiting
Stanford, California, United States, 94305
Contact: Kathy Turner, RN, NP    650-724-6850   
Principal Investigator: Kathy Turner RN, NP         
Sub-Investigator: Lynn M Westphal         
Sponsors and Collaborators
Stanford University
Principal Investigator: Kathy Turner RN, NP Stanford University
  More Information

Responsible Party: Kathy Turner RN, NP, Stanford University School of Medicine Identifier: NCT00788502     History of Changes
Other Study ID Numbers: SU-11052008-1334
Study First Received: November 6, 2008
Last Updated: May 21, 2010

Additional relevant MeSH terms:
Genital Diseases, Male
Genital Diseases, Female processed this record on May 23, 2017